Category - Executive Moves

Executive Moves

Soricimed names Vaughn Embro-Pantalony as chairman, Susan Hicks to BOD

Closely-held Soricimed Biopharma named Vaughn Embro-Pantalony, a current director, as chairman and Susan Hicks to its board, both effective immediately. Mr. Embro-Pantalony, who joined Soricimed’s board in March 2018...

September 4, 2018

Executive Moves

Scott Smith joins board of Spring Bank Pharma

Spring Bank Pharmaceuticals (NASDAQ:SBPH) named Scott Smith as an independent member of the board, replacing Jonathan Bates, who is stepping down as a director after 10 years of service with the company.

August 17, 2018

Executive Moves

James Molloy joins equity research team at A.G.P./Alliance

James Molloy has joined A.G.P./Alliance Global Partners as a managing director and biotechnology and specialty pharmaceuticals equity research analyst. He will provide coverage of companies in several therapeutic...

August 14, 2018

Executive Moves

Carin Fradin joins JMP as a managing director investment banking

Carin Fradin has joined JMP Group (NYSE:JMP) as a managing director in its investment banking division.

June 19, 2018

Executive Moves

Rigel Pharma names Dean Schorno as EVP and CFO

Rigel Pharmaceuticals (NASDAQ:RIGL) appointed Dean Schorno as EVP and CFO.

May 30, 2018

Executive Moves

Dr. Mani Foroohar joins Leerink research team covering therapeutics

Dr. Mani Foroohar has joined Leerink Partners’ research team as a managing director and senior research analyst covering therapeutics stocks.

May 21, 2018

Executive Moves

Complexa names Francisco Salva as CEO, president

Closely-held Complexa appointed Francisco Salva as the company’s new CEO and president, effective immediately.

May 14, 2018

Executive Moves

Titan Pharma names Federico Seghi Recli as a director

Titan Pharmaceuticals (NASDAQ:TTNP) announced the appointment of Federico Seghi Recli to its board. An executive with over 24 years of leadership experience within the pharmaceutical industry, Mr. Seghi Recli has served...

May 14, 2018

Executive Moves

Aaron Davidson named CFO and SVP corporate development of Profound Medical

Profound Medical (TSXV:PRN; OTCQX:PRFMF) strengthened its management team, naming Aaron Davidson as CFO and SVP of corporate development, effective May 3, 2018. In a statement, Arun Menawat, CEO, said Mr. Davidson’s...

May 1, 2018

Executive Moves

Maxim Group expands biotech equity research team

Maxim Group expanded its equity research platform with the appointment of Caroline Palomeque as a SVP and a senior biotechnology analyst.

April 30, 2018

Category - Executive Moves

Subscribe